Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global reportBorisov Se, Valentina Marchese, Alena Aleksa et al.|European Respiratory Journal|2019Cited by 176
Reducing tuberculosis transmission: a consensus document from the World Health Organization Regional Office for EuropeGiovanni Battista Migliori, Masoud Dara, Edward A. Nardell et al.|European Respiratory Journal|2019Cited by 130
Early COVID-19 pandemic’s toll on tuberculosis services, WHO European Region, January to June 2020Masoud Dara, Martin J. Boeree, Giorgi Kuchukhidze et al.|Eurosurveillance|2021Cited by 38
Factors Associated with Unfavourable Treatment Outcomes in Patients with Tuberculosis: A 16-Year Cohort Study (2005–2020), Republic of Karakalpakstan, UzbekistanJamshid Gadoev, Masoud Dara, Damin Asadov et al.|International Journal of Environmental Research and Public Health|2021Cited by 9
Integrated use of laboratory services for multiple infectious diseases in the WHO European Region during the COVID-19 pandemic and beyondDaniel Simões, Masoud Dara, Soudeh Ehsani et al.|Eurosurveillance|2022Cited by 9